Literature DB >> 10378916

Level ground and uphill cycling ability in professional road cycling.

S Padilla1, I Mujika, G Cuesta, J J Goiriena.   

Abstract

PURPOSE: To evaluate the physiological capacities and performance of professional road cyclists in relation to their morphotype-dependent speciality.
METHODS: 24 world-class cyclists, classified as flat terrain (FT, N = 5), time trial (TT, N = 4), all terrain (AT, N = 6). and uphill (UH, N = 9) specialists, completed an incremental laboratory cycling test to assess maximal power output (Wmax), maximal oxygen uptake (VO2max), lactate threshold (LT), and onset of blood lactate accumulation (OBLA).
RESULTS: UH had a higher frontal area (FA):body mass (BM) ratio (5.23 +/- 0.09 m2 x kg(-1) x 10(-3)) than FT and TT (P < 0.05). FT showed the highest absolute Wmax (481 +/- 18 W), and UH the highest Wmax relative to BM (6.47 +/- 0.33 W x kg(-1)). WLT and W(OBLA) values were significantly higher in FT (356 +/- 41 and 417 +/- 45 W) and TT (357 +/- 41 and 409 +/- 46 W) than in UH (308 +/- 46 and 356 +/- 41). Scaling of these values relative to FA and BM exponents 0.32 and 0.79 minimized group differences, but considerable differences among mean group values remained. FT and TT had the highest Wmax per FA unit (1300 +/- 62 and 1293 +/- 57 W x m2), whereas TT had the highest absolute W x kg(-0.32) and W x kg(-0.79), as well as W x kg(-0.32), W x kg(-0.79), and W x m2 at the LT and OBLA.
CONCLUSIONS: i) Scaling of maximal and submaximal physiological values showed a performance advantage of TT over FT, AT, and UH in all cycling terrains and conditions; and ii) mass exponents of 0.32 and 1 were the most appropriate to evaluate level and uphill cycling ability, respectively, whereas absolute Wmax values are recommended for performance-prediction in short events on level terrain, and W(LT) and W(OBLA) in longer time trials and uphill cycling.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10378916     DOI: 10.1097/00005768-199906000-00017

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  32 in total

1.  Effects of endurance training on the isocapnic buffering and hypocapnic hyperventilation phases in professional cyclists.

Authors:  J L Chicharro; J Hoyos; A Lucía
Journal:  Br J Sports Med       Date:  2000-12       Impact factor: 13.800

Review 2.  Nutritional practices of male and female endurance cyclists.

Authors:  L M Burke
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

Review 3.  Physiological and performance characteristics of male professional road cyclists.

Authors:  I Mujika; S Padilla
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

Review 4.  Adaptations to training in endurance cyclists: implications for performance.

Authors:  J A Hawley; N K Stepto
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

Review 5.  Improving cycling performance: how should we spend our time and money.

Authors:  A E Jeukendrup; J Martin
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

Review 6.  Physiology of professional road cycling.

Authors:  A Lucia; J Hoyos; J L Chicharro
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

7.  Gear, inertial work and road slopes as determinants of biomechanics in cycling.

Authors:  Piero Mognoni; Pietro E di Prampero
Journal:  Eur J Appl Physiol       Date:  2003-10-07       Impact factor: 3.078

8.  Which laboratory variable is related with time trial performance time in the Tour de France?

Authors:  A Lucia; J Hoyos; M Pérez; A Santalla; C P Earnest; J L Chicharro
Journal:  Br J Sports Med       Date:  2004-10       Impact factor: 13.800

9.  Body size as a determinant of the 1-h cycling record at sea level and altitude.

Authors:  Daniel P Heil
Journal:  Eur J Appl Physiol       Date:  2004-12-14       Impact factor: 3.078

Review 10.  Compression Garments and Recovery from Exercise: A Meta-Analysis.

Authors:  Freddy Brown; Conor Gissane; Glyn Howatson; Ken van Someren; Charles Pedlar; Jessica Hill
Journal:  Sports Med       Date:  2017-11       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.